Speciality Medicines Ltd Quarterly Result

Speciality Medicines Ltd Quarterly Result

Image

Speciality Medicines Ltd

NSE: SPML

Net Profit - Last Quarter

₹ - Cr.

Last updated on: Jun 15, 2026

Speciality Medicines Ltd Quarterly Results Key Highlights

No data available

Speciality Medicines Ltd Quarterly Results Analysis

Market Price of Speciality Medicines Ltd

1M

1Y

3Y

5Y

Monitoring Speciality Medicines Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Jun 2026203
11 Jun 2026204.5
10 Jun 2026204.7
09 Jun 2026215
08 Jun 2026214.1
05 Jun 2026216.05
04 Jun 2026220.1
03 Jun 2026209.65
02 Jun 2026214
01 Jun 2026210

Historical Revenue of Speciality Medicines Ltd

No data available

* All values are in crore

Historical EBITDA of Speciality Medicines Ltd

No data available

* All values are in crore

Historical Net Profit of Speciality Medicines Ltd

No data available

* All values are in crore

Speciality Medicines Ltd News Hub

BSE SME Speciality Medicines debuts without fireworks

The scrip was listed at Rs 124, matching the initial public offer (IPO) price. The counter hit a hig

Read more

30 Mar 26

Sensex, Nifty trade with sharp losses; PSU Bank shares drop

The domestic equity benchmarks remained under pressure in mid-afternoon trade with sharp losses as i

Read more

23 Apr 26

Speciality Medicines inks commercial agreement valued at USD 2 million

Speciality Medicines has finalized a commercial arrangement with an international entity that specia

Read more

23 Apr 26

Speciality Medicines to discuss results

Speciality Medicines will hold a meeting of the Board of Directors of the Company on 28 May 2026.

Read more

23 May 26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

About Speciality Medicines Ltd

  • Speciality Medicines Limited was originally incorporated as 'Speciality Medicines Private Limited' as a Private Limited Company, dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre.
  • Later on, the status was converted to Public Limited and the name of the Company was changed to 'Speciality Medicines Limited' and a fresh Certificate of Incorporation dated June 25, 2024 was issued to the Company by Registrar of Companies. The Company is engaged in marketing & distribution of finished formulations of Specialty pharmaceuticals - high-cost oral or injectable medications used to treat complex chronic conditions in Domestic as well as International Market.
  • The Company has presence over 35 countries. The Company deal in Specialty pharmaceuticals finished formulations Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nasal Spray, Ointment, Ophthalmic, Oral Solution, Oral Suspension, Sachet, Suspension and Tablet.

FAQs for Quarterly Results of Speciality Medicines Ltd

What key financial metrics are included in Speciality Medicines Ltd's quarterly results?

Key financial metrics in Speciality Medicines Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Speciality Medicines Ltd announce its quarterly results?

Speciality Medicines Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Speciality Medicines Ltd's quarterly performance impact its stock price?

Speciality Medicines Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Speciality Medicines Ltd's quarterly results on dividends?

The impact of Speciality Medicines Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Speciality Medicines Ltd's quarterly results?

Yes, Speciality Medicines Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions